Effects and differentiation activity of IGF-I, IGF-II, insulin and preptin on human primary bone cells

Growth Factors

Volumn 31, Issue 2, 2013, Pages 57-65

  Bosetti, Michela ^a   Sabbatini, Maurizio ^a   Nicolì, Elena ^a   Fusaro, Luca ^a   Cannas, Mario ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Bone metabolism; Human primary bone cells; Metabolic factors; Mineralization

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALKALINE PHOSPHATASE; CALCEIN; COLLAGEN TYPE 1; OSTEOCLAST DIFFERENTIATION FACTOR; PEPTIDE HORMONE; PREPTIN; RECOMBINANT HUMAN INSULIN; SOMATOMEDIN B; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ARTICLE; BONE CELL; BONE MARROW CELL; BONE MASS; BONE METABOLISM; BONE MINERALIZATION; CALCIUM TRANSPORT; CELL ACTIVITY; CELL CULTURE; CELL DIFFERENTIATION; CELL NUCLEUS; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; DEREGULATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MULTINUCLEAR CELL; OSTEOBLAST; OSTEOCLAST; OSTEOCLAST ACTIVITY; OSTEOCLASTOGENESIS; OSTEOLYSIS; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; TELOMERIC REPEAT AMPLIFICATION PROTOCOL;

BONE AND BONES; BONE RESORPTION; CELL DIFFERENTIATION; CELLS, CULTURED; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; OSTEOBLASTS; OSTEOCLASTS; PEPTIDE FRAGMENTS;

EID: 84876219685     PISSN: 08977194     EISSN: 10292292     Source Type: Journal    
DOI: 10.3109/08977194.2013.770392     Document Type: Article

References (29)

1. Abrahamsen B, Rohold A, Henriksen JE, Beck-Nielsen H. 2000. Correlations between insulin sensitivity and bone mineral density in non-diabetic men. Diabet Men 17:124-129.
2. Ahmed LA, Schirmer H, Berntsen GK, Fonnebo V, Joakimsen RMJ. 2006. Features of the metabolic syndrome and the risk of non-vertebral fractures: The Tromso study. Osteoporos Int 17: 426-432.
3. Bjarnason NH, Henriksen EE, Alexandersen P, Christgau S, Henriksen DB, Christiansen C. 2002. Mechanism of circadian variation in bone resorption. Bone 30:307-313.
4. Bosetti M, Vernè E, Ferraris M, Ravaglioli A, Cannas M. 2001. In vitro characterization of zirconia by bioactive glass. Biomaterials 22:987-994.
5. Buchanan CM, Phillips AR, Cooper GJ. 2001. Preptin derived from proinsulin-like growth factor II (proIGF-II) is secreted from pancreatic islet beta-cells and enhances insulin secretion. Biochem J 360:431-439.
6. Canalis E. 2009. Growth factor control of bone mass. J Cell Biochem 108:769-777.
7. Clowes JA, Hannon RA, Yap TS, Hoyle NR, Blumsohn A, Eastell R. 2002. Effect of feeding on bone turnover markers and its impact on biological variability of measurements. Bone 30:886-890.
8. Cooper GJS. 1994. Amylin compared with calcitonin gene-related peptide: Structure, biology, and relevance to metabolic disease. Endocrine Rev 15:163-201.
9. Cornish J, Callon KE, Gasser JA, Bava U, Gardiner EM, Coy DH, Cooper GJ, Reid IR. 2000. Systemic administration of a novel octapeptide, amylin-(1-8), increase bone volume in male mice. Am J Physiol Endocrinol Metab 279:E730-E735.
10. Cornish J, Callon KE, Bava U, Watson M, Xu X, Lin JM, Chan VA, Grey AB, Naot D, Buchanan CM, Cooper GJ, Reid IR. 2007. Preptin, another peptide product of the pancreatic beta-cell, is osteogenic in vitro and in vivo. Am J Physiol Endocrinol Metab 292:E117-E122.
11. Ellegaard M, Thorkildsen C, Petersen S, Petersen JS, Jørgensen NR, Just R, Schwarz P, Ramirez MT, Stahlhut M. 2010. Amylin (1-8) is devoid of anabolic activity in bone. Calcif Tissue Int 86: 249-260.
12. Fattore AD, Teti A, Rucci N. 2012. Bone cells and the mechanisms of bone remodelling. Front Biosci (Elite Ed.) 4: 2302-2321.
13. Freude T, Braun KF, Haug A, Pscherer S, Stöckle U, Nussler AK, Ehnert S. 2012. Hyperinsulinemia reduces osteoblast activity in vitro via upregulation of TGF-b. J Mol Med (Berl) 90(11): 1257-1266.
14. Fulzele K, Clemens TL. 2012. Novel functions for insulin in bone. Bone 50:452-456.
15. Fulzele K, DiGirolamo DJ, Liu Z, Xu J, Messina JL, Clemens TL. 2007. Disruption of the insulin-like growth factor type 1 receptor in osteoblasts enhances insulin signaling and action. J Biol Chem 282:25649-25658.
16. Gazzerro E, Canalis E. 2006. Skeletal actions of insulin-like growth factors. Expert Rev Endocrinol Metab 1:47-56.
17. Hale LV, Ma YF, Santerre RF. 2000. Semi-quantitative fluorescence analysis of calcein binding as a measurement of in vitro mineralization. Calcif Tissue Int 67:80-84.
18. Hayden JM, Mohan S, Baylink DJ. 1995. The insulin-like growth factor system and the coupling of formation to resorption. Bone 17:93S-98S.
19. Hemingway F, Taylor R, Knowles HJ, Athanasou NA. 2011. RANKL-indipendent human osteoclast formation with APRIL, NGF, IGF-I and IGF-II. Bone 48(6):938-944.
20. Hill PA, Reynold JJ, Meikle MC. 1995. Osteoblasts mediate insulinlike growth factor-I and-II stimulation of osteoclast formation and function. Endocrinology 136:124-131.
21. Laviola L, Natalicchio A, Perrini S, Giorgino F. 2008. Abnormalities of IGF-I signaling in the patogenesis of disease of the bone, brain, and fetoplacental unit in human. Am J Physiol Endocrinol Metab 295:E991-E999.
22. McCabe L, Zhang J, Raehtz S. 2011. Understanding the skeletal pathology of type 1 and 2 diabetes mellitus. Crit Rev Eukaryot Gene Expr 21:187-206.
23. Minuto F, Palermo C, Arvigo M, Barreca AM. 2005. The IGF system and bone. J Endocrinol Invest 28:8-10.
24. Mochizuki H, Hakeda Y, Wakatsuki N, Usui N, Akashi S, Sato T, Tanaka K, Kumegawa M. 1992. Insulin-like growth factor-I formation and activation of osteoclasts. Endocrinology 131: 1075-1780.
25. Rajpathak SN, Gunter MJ, Wylie-Rosett J, Ho GY, Japlan RC, Muzumdar R, Rohan TE, Strickler HD. 2009. The role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes. Diabetes Metab Res Rev 25: 3-12.
26. Sayers A, Lawlor DA, Sattar N, Tobias JH. 2012. The association between insulin levels and cortical bone: findings from a cross-sectional analysis of pQCT parameters in adolescents. J Bone Mineral Res 27:610-618.
27. Thomas DM, Hards DK, Rogers SD, Ng KW, Best JD. 1996. Insulin receptor expression in bone. J Bone Miner Res 11: 1312-1320.
28. Thomas DM, Udagawa N, Hards DK, Quinn JM, Moseley JM, Findlay DM, Best JD. 1998. Insulin receptor expression in primary and cultured osteoclast-like cells. Bone 23:181-186.
29. Walsh JS, Henriksen DB. 2010. Feeding and bone. Arch Biochem Biophys 503:11-19.